or
Bookmark and Share
Reagents for preparing and method of preparing prostaglandins
   
Document Number
US Patent 3867375
Issued Date
February 18, 1975
Link
Inventors
Map
Abstract
Octenol ether copper.sup.(I) lithium reagents which are useful in preparing prostaglandin derivatives and methods of preparing such reagents and methods of preparing prostaglandin derivatives using such reagents. The prostaglandin derivatives exhibit prostaglandin-like pharmacological properties and thus are useful where such agents are indicated.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
15
Comments:
no comments yet
Owner
Syntex (U.S.A.) Inc. (Palo Alto, CA)
Published
February 18, 1975
Application Number
05/252,725
Filed
May 12, 1972
US Classification
549/422   549/421 556/112 556/13 556/22 556/32 560/118 560/121 560/53 562/503
Int'l Classification
C07C   405/00   (20060101)   C07C   45/00   (20060101)   C07C   45/63   (20060101)   C07D   309/00   (20060101)   C07D   309/12   (20060101)   C07F   1/08   (20060101)   C07F   1/00   (20060101)  
USPTO Field of Search
260/24R   260/468D   260/514D  
Related Patents
3920827 - Pharmaceutical compositions containing therapeutic 5',6'-dihydro-2H-pyran-4'-yloxy prostaglandins - Owned by ALZA Corporation (Palo Alto, CA)

Novel 5',6'-dihydro-2H-pyran-4'-yl prostaglandin ether compounds of the formula ##SPC1## Wherein R.sub.1 is hydrogen or lower alkyl; R.sub.2 and R.sub.3 are hydrogen when Y is a single bond and R.sub.2 and R.sub.3 are absent when Y is a double bond; R.sub.4 is ##SPC2## R.sub.5 is hydrogen or ##SPC3## C.sub.1 is >C=O, ##EQU1## C.sub.2 is >C--H when X is a double bond; and C.sub.2 is ##EQU2## when X is a single bond; ##EQU3## when X is a double bond and ##EQU4## when X is a single bond; Z.sub.1 is a cis or trans --CH=CH-- or --CH.sub.2 CH.sub.2 --; Z.sub.2 is trans --CH=CH-- or --CH.sub.2 CH.sub.2 --; n is 1 to 5; m is 0 to 5; and the non-toxic salts. The novel compounds possess pharmacological properties as modifiers of smooth muscle activity, gastric secretion, blood pressure, lipolysis and the reproductive system. The compounds also induce labor and menses and they can be used for the relief of asthma and nasal congestion and as platelet anti-aggregation agents.

4181798 - Methylenecyclopentane derivatives - Owned by The Upjohn Company (Kalamazoo, MI)

Methylenecyclopentane derivatives, for example ##STR1## wherein R.sub.2 is a blocking group such as tetrahydropyranyl, and a process for preparing them; said derivatives having utility as prostaglandin intermediates.

4195178 - Methylenecyclopentane derivatives - Owned by The Upjohn Company (Kalamazoo, MI)

Methylenecyclopentane derivatives, for example ##STR1## wherein R.sub.2 is a blocking group such as tetrahydropyranyl, and a process for preparing them; said derivatives having utility as prostaglandin intermediates.

6819467 - Reduced ultraviolet radiation transmitting, variable transmission, glazing assembly - Owned by Donnelly Corporation (Holland, MI)

A glazing/window assembly with reduced ultraviolet (UV) radiation transmission may include at least a pair of glass panels or other elements confining an electrochromic medium therebetween. Ultraviolet radiation reducing material is incorporated for reducing ultraviolet radiation transmission through the assembly. The ultraviolet radiation reducing material comprises at least one of an ultraviolet absorber, an ultraviolet absorbing polymer, and an ultraviolet absorbing glass. At least one of a laminated glass panel, tempered glass panel and a polymeric layer is provided to prevent injury upon impact to the assembly. A color tint may be included in the assembly to provide a tint to transmitted light.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us